In this case study you will further explore the link between antibiotic use and antibiotic resistance, by looking at a specific class of antibiotics, the cephalosporins.
Cephalosporins are a group of ß-lactam antibiotics which target cell wall synthesis. Discovered in the late 1940s, cephalosporins have a wide range of activity, have few side effects, and are one of the most commonly used antibiotics in the world.
Allow about 25 minutes
The images provided for this case study are taken from Resistance Map, a web-based programme that allows antibiotic use and antibiotic resistance data from different countries to be compared.
Study Figures 6a and 6b which compare cephalosporin use from 2000 to 2015 in the UK and South Africa. Then answer the following questions.
Now study Figures 7a and 7b which compare cephalosporin resistance among K. pneumoniae and E. coli clinical isolates in the UK and South Africa. Then answer the following questions.
In South Africa, there was a slight increase in cephalosporin resistance in both K. pneumoniae and E. coli from 2011 to 2015.
What conclusions, if any, can you draw from the data in Figures 6 and 7?
The link between antibiotic use and antibiotic resistance is complex and factors other than the amount of antibiotics used can affect the levels of resistance found. For example, the underlying mechanism by which the bacterial population becomes resistant to the antibiotic and the frequency at which resistance spreads is also important. You will learn more about this in Weeks 3 and 4.
Note also that the resistance data in Figures 6 and 7 are for clinical isolates from healthcare settings, whereas antibiotics are increasingly used for non-therapeutic purposes such as agriculture.
In the next section you will explore what the rising global levels of antibiotic resistance mean for us now and in the future.
OpenLearn - Understanding antibiotic resistance
Except for third party materials and otherwise, this content is made available under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Licence, full copyright detail can be found in the acknowledgements section. Please see full copyright statement for details.